The 2025 Awards will open for entries in March 2025 - more details to follow shortly.
Linda joined the Biopharma industry in 1983 and has spent the last 30 years in regulatory strategy, intelligence and policy roles. She is Executive Director, Chief of Staff, Global Oncology Regulatory Strategy, Pfizer and an Assistant Adjunct Professor in the Temple University RAQA graduate program. Previous industry roles include Chief of Staff and Head of the Regulatory Centers of Excellence at Seagen, Inc; Head of North America Regulatory Policy & Intelligence at Sanofi; and senior regulatory strategy roles at Bayer and GSK. She attained Regulatory Affairs Certification for the US, Canada, and Europe and was inducted into the 2011 Class of RAPS Fellows. Linda was honored with the RAPS 2020 Founders Award and the DIA 2012, 2019, and 2022 Excellence in Volunteer Leadership Award. She is most proud of her role as an educator and mentor to those entering the regulatory profession.